Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation : association with chronic graft-versus-host disease and improved overall survival
- Author
- LIM, Z. Y1 ; INGRAM, W1 ; BRAND, R2 ; AKTHARI, M1 ; MILOJKOVIC, D1 ; HO, A. Y. L1 ; DEVEREUX, S1 ; PAGLIUCA, A1 ; DUARTE, R. F1 ; MUFTI, G. J1
[1] Department of Haematological Medicine, Kings College London and Kings College Hospital, London, United Kingdom
[2] Department of Medical Statistics and Biolnformatics, Leiden University Medical Center, Leiden, Netherlands - Source
Bone marrow transplantation (Basingstoke). 2007, Vol 40, Num 8, pp 747-752, 6 p ; ref : 21 ref
- CODEN
- BMTRE9
- ISSN
- 0268-3369
- Scientific domain
- Medical oncology; Graft, transplantation; Hematology
- Publisher
- Nature Publishing Group, Basingstoke
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- alemtuzumab allogeneic transplantation gammopathies reduced intensity
- Keyword (fr)
- Alemtuzumab Anticorps monoclonal Cellule hématopoïétique Cellule souche Conditionnement atténué Greffe Homogreffe Hématologie Immunodépresseur Immunomodulateur Intensité Maladie greffon hôte Survie Maladie chronique Immunopathologie
- Keyword (en)
- Alemtuzumab Monoclonal antibody Hematopoietic cell Stem cell Non myeloablative treatment Graft Homograft Hematology Immunosuppressive agent Immunomodulator Intensity Graft versus host reaction Survival Chronic disease Immunopathology
- Keyword (es)
- Alemtuzumab Anticuerpo monoclonal Célula hematopoyética Célula primitiva Tratamiento no mieloablativo Injerto Homoinjerto Hematología Inmunodepresor Inmunomodulador Intensidad Enfermedad injerto huesped Sobrevivencia Inmunopatología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B27 Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy / 002B27D Transfusions. Complications. Transfusion reactions. Cell and gene therapy / 002B27D02 Bone marrow, stem cells transplantation. Graft versus host reaction
- Discipline
- Anaesthesia. Reanimation. Transfusion. Cell therapy and gene therapy
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 19163359
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1038/sj.bmt.1705805 
https://dx.doi.org/10.1038/sj.bmt.1705805
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bmt.1705805\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:202:\"Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation : association with chronic graft-versus-host disease and improved overall survival\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Bone marrow transplantation (Basingstoke)\";s:9:\"\u0000*\u0000stitle\";s:37:\"Bone marrow transplant. (Basingstoke)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"40\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"747\";s:8:\"\u0000*\u0000epage\";s:3:\"752\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0268-3369\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"LIM\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Z. Y\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:9:\"INGRAM, W\";i:1;s:8:\"BRAND, R\";i:2;s:10:\"AKTHARI, M\";i:3;s:13:\"MILOJKOVIC, D\";i:4;s:11:\"HO, A. Y. L\";i:5;s:11:\"DEVEREUX, S\";i:6;s:11:\"PAGLIUCA, A\";i:7;s:12:\"DUARTE, R. F\";i:8;s:11:\"MUFTI, G. J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BMTRE9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:202:\"Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation : association with chronic graft-versus-host disease and improved overall survival\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bmt.1705805\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:202:\"Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation : association with chronic graft-versus-host disease and improved overall survival\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Bone marrow transplantation (Basingstoke)\";s:9:\"\u0000*\u0000stitle\";s:37:\"Bone marrow transplant. (Basingstoke)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"40\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"747\";s:8:\"\u0000*\u0000epage\";s:3:\"752\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0268-3369\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"LIM\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Z. Y\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:9:\"INGRAM, W\";i:1;s:8:\"BRAND, R\";i:2;s:10:\"AKTHARI, M\";i:3;s:13:\"MILOJKOVIC, D\";i:4;s:11:\"HO, A. Y. L\";i:5;s:11:\"DEVEREUX, S\";i:6;s:11:\"PAGLIUCA, A\";i:7;s:12:\"DUARTE, R. F\";i:8;s:11:\"MUFTI, G. J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BMTRE9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:202:\"Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation : association with chronic graft-versus-host disease and improved overall survival\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bmt.1705805\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bmt.1705805\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:202:\"Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation : association with chronic graft-versus-host disease and improved overall survival\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Bone marrow transplantation (Basingstoke)\";s:9:\"\u0000*\u0000stitle\";s:37:\"Bone marrow transplant. (Basingstoke)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"40\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"747\";s:8:\"\u0000*\u0000epage\";s:3:\"752\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0268-3369\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"LIM\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Z. Y\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:9:\"INGRAM, W\";i:1;s:8:\"BRAND, R\";i:2;s:10:\"AKTHARI, M\";i:3;s:13:\"MILOJKOVIC, D\";i:4;s:11:\"HO, A. Y. L\";i:5;s:11:\"DEVEREUX, S\";i:6;s:11:\"PAGLIUCA, A\";i:7;s:12:\"DUARTE, R. F\";i:8;s:11:\"MUFTI, G. J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BMTRE9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:202:\"Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation : association with chronic graft-versus-host disease and improved overall survival\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bmt.1705805\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:202:\"Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation : association with chronic graft-versus-host disease and improved overall survival\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Bone marrow transplantation (Basingstoke)\";s:9:\"\u0000*\u0000stitle\";s:37:\"Bone marrow transplant. (Basingstoke)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"40\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"747\";s:8:\"\u0000*\u0000epage\";s:3:\"752\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0268-3369\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"LIM\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Z. Y\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:9:\"INGRAM, W\";i:1;s:8:\"BRAND, R\";i:2;s:10:\"AKTHARI, M\";i:3;s:13:\"MILOJKOVIC, D\";i:4;s:11:\"HO, A. Y. L\";i:5;s:11:\"DEVEREUX, S\";i:6;s:11:\"PAGLIUCA, A\";i:7;s:12:\"DUARTE, R. F\";i:8;s:11:\"MUFTI, G. J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BMTRE9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:202:\"Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation : association with chronic graft-versus-host disease and improved overall survival\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bmt.1705805\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:202:\"Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation : association with chronic graft-versus-host disease and improved overall survival\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Bone marrow transplantation (Basingstoke)\";s:9:\"\u0000*\u0000stitle\";s:37:\"Bone marrow transplant. (Basingstoke)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"40\";s:8:\"\u0000*\u0000issue\";s:1:\"8\";s:8:\"\u0000*\u0000spage\";s:3:\"747\";s:8:\"\u0000*\u0000epage\";s:3:\"752\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0268-3369\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"LIM\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Z. Y\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:9:\"INGRAM, W\";i:1;s:8:\"BRAND, R\";i:2;s:10:\"AKTHARI, M\";i:3;s:13:\"MILOJKOVIC, D\";i:4;s:11:\"HO, A. Y. L\";i:5;s:11:\"DEVEREUX, S\";i:6;s:11:\"PAGLIUCA, A\";i:7;s:12:\"DUARTE, R. F\";i:8;s:11:\"MUFTI, G. J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BMTRE9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:202:\"Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation : association with chronic graft-versus-host disease and improved overall survival\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
